The Wyss Institute is seeking a Scientist I to drive a discovery effort that combines genetic (e.g., CRISPR or shRNA-based) and small molecule screening with human Organ Chips. The goal is to identify therapeutic targets and candidate drugs that mitigate injury or accelerate healing after ionizing radiation exposure. While effective radiation countermeasures are needed for medical and military defense situations, there are few FDA-approved drugs for this indication. We are aiming to add to that list. This is an important role in a fast-paced multi-year translational and collaborative project that spans the lung, intestine, bone marrow, and immune Organ Chips. [64939BR]